Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Shojiro Kyotani"'
Autor:
Masahito Morimoto, Ichiro Suzaki, Seishi Shimakawa, Toshiaki Hashimoto, Tadanori Nakatsu, Shigeaki Hamada, Shojiro Kyotani
Publikováno v:
Clinical Case Reports, Vol 8, Iss 7, Pp 1166-1170 (2020)
Abstract Carbamazepine often causes drug‐induced hyponatremia. Hyponatremia due to carbamazepine may be improved by changing to the same mechanism of action, lacosamide.
Externí odkaz:
https://doaj.org/article/c6c706c4ab514a01a177bf385a3586b1
Autor:
Taisuke Kitaoka, Masahito Morimoto, Toshiaki Hashimoto, Yoshimi Tsuda, Tadanori Nakatsu, Shojiro Kyotani
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 6, Iss 1, Pp 1-8 (2020)
Abstract Background Autism spectrum disorder (ASD) is a neurodevelopmental disorder, mainly characterized by impairment of social communication and restricted interests. ASD is frequently accompanied by attention deficit hyperactivity disorder (ADHD)
Externí odkaz:
https://doaj.org/article/66663ab7ad7b455db5ec0cd460615cfa
Autor:
Masahito Morimoto, Toshiaki Hashimoto, Yoshimi Tsuda, Tadanori Nakatsu, Taisuke Kitaoka, Shojiro Kyotani
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0233550 (2020)
There are several studies on oxidative stress of Autism Spectrum Disorder (ASD), but in these cases there is no study to measure oxidative stress and antioxidant capacity at the same time or studies considering childhood development. Therefore, this
Externí odkaz:
https://doaj.org/article/5a81185b535c4204a50861c928d0cad6
Autor:
Shigeaki Hamada, Toshiaki Hashimoto, Ichiro Suzaki, Seishi Shimakawa, Shojiro Kyotani, Masahito Morimoto, Tadanori Nakatsu
Publikováno v:
Clinical Case Reports, Vol 8, Iss 7, Pp 1166-1170 (2020)
Clinical Case Reports
Clinical Case Reports
Carbamazepine often causes drug‐induced hyponatremia. Hyponatremia due to carbamazepine may be improved by changing to the same mechanism of action, lacosamide.
Publikováno v:
Journal of the Chinese Medical Association. 82:651-654
Measurement of the levels of the derivatives of reactive oxygen metabolites (d-ROMs) and of the biological antioxidant potential (BAP) enables simultaneous assessment of oxidation degree and antioxidant capacity, using the same sample and testing equ
Autor:
Junko Yokota, Shojiro Kyotani
Publikováno v:
Journal of the Chinese Medical Association, Vol 81, Iss 6, Pp 511-519 (2018)
Background: This study aims to evaluate the influence of nanoparticle size on the in vitro percutaneous penetration and retention and in vivo anti-inflammatory efficacy of percutaneously delivered non-steroidal anti-inflammatory drugs. Methods: Indom
Autor:
Masahito Morimoto, Toshiaki Hashimoto, Shojiro Kyotani, Yoshimi Tsuda, Taisuke Kitaoka, Tadanori Nakatsu
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 5, p e0233550 (2020)
PLoS ONE, Vol 15, Iss 5, p e0233550 (2020)
There are several studies on oxidative stress of Autism Spectrum Disorder (ASD), but in these cases there is no study to measure oxidative stress and antioxidant capacity at the same time or studies considering childhood development. Therefore, this
Publikováno v:
Journal of Clinical Medicine Research
Background: Epilepsy is a common complication in patients with severe motor and intellectual disabilities (SMID). There are no reports as yet of the effects of these medications in vivo other than their epileptic efficacy. The purpose of this study
Publikováno v:
Journal of the Chinese Medical Association, Vol 80, Iss 1, Pp 19-28 (2017)
Background Patients with severe motor and intellectual disabilities (SMID) are those who have both severe intellectual disabilities and severe physical disabilities. Intractable epilepsy is often associated with SMID. The purpose of this study was to
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 43:571-573
WHAT IS KNOWN AND OBJECTIVE Dravet syndrome (DS) is an intractable epilepsy syndrome. The three-drug combination therapy of sodium valproate (VPA), clobazam (CLB) and stiripentol (STP) is recommended worldwide. CASE SUMMARY We present a case of DS, i